YAL
ARVN icon

Your Advocates Ltd’s Arvinas ARVN Stock Holding History

Your Advocates Ltd’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-115
Closed -$4K – 139
2020
Q2 		$4K Buy
+115
New +$4.88K ﹤0.01% 110

Other funds holding ARVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Your Advocates Ltd's ARVN Position: Q3 2020 in Review

Your Advocates Ltd sold out of Arvinas (ARVN) in Q3 2020, closing a stake of 115 shares — an estimated $4K sold.

Your Advocates Ltd first reported a position in ARVN in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 141 funds tracked by Wall St. Rank hold ARVN as of Q3 2020.

  • Your Advocates Ltd reported no remaining Arvinas position as of Q3 2020 after selling out during the quarter.
  • Your Advocates Ltd sold 115 Arvinas shares in Q3 2020, an estimated $4K.
  • Your Advocates Ltd first reported a position in Arvinas in Q2 2020 and held it in 1 quarter.
  • Your Advocates Ltd's Arvinas position peaked at $4K in Q2 2020.
  • 141 funds tracked by Wall St. Rank held Arvinas as of Q3 2020.

Based on Your Advocates Ltd's 13F filing for Q3 2020, filed 9 Nov 2020.